|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 03, 2019 11:18PM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 12:07AM
|
|
Re: Right of first refusal
|
2
|
Resverlogix Corp.
|
Mar 04, 2019 11:53AM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 01:06PM
|
|
Re: Right of first refusal
|
2
|
Resverlogix Corp.
|
Mar 04, 2019 01:24PM
|
|
Re: Right of first refusal
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 01:29PM
|
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
2
|
Resverlogix Corp.
|
Feb 14, 2021 05:56PM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
9
|
Resverlogix Corp.
|
Sep 18, 2020 12:51PM
|
|
Re: RSU's awarded
|
7
|
Resverlogix Corp.
|
Sep 18, 2019 09:29PM
|
|
Re: RSU's awarded
|
4
|
Resverlogix Corp.
|
Sep 19, 2019 09:48AM
|
|
Re: RSU's awarded
|
4
|
Resverlogix Corp.
|
Sep 19, 2019 11:01AM
|
|
Re: Rules on Disclosure
|
3
|
Resverlogix Corp.
|
Sep 26, 2019 11:29PM
|
|
Re: Rules on Disclosure
|
3
|
Resverlogix Corp.
|
Sep 26, 2019 11:58PM
|
|
Re: Rumors starting again
|
5
|
Zenith Epigenetics
|
Nov 09, 2020 02:41PM
|
|
Re: Rumors....
|
7
|
Resverlogix Corp.
|
Nov 21, 2019 11:33AM
|
|
Re: rumours have been flying around the last ...
|
8
|
Zenith Epigenetics
|
Mar 01, 2021 01:00PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
10
|
Resverlogix Corp.
|
May 09, 2022 10:46AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
6
|
Resverlogix Corp.
|
May 09, 2022 01:10PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
7
|
Resverlogix Corp.
|
Jan 18, 2021 11:04AM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
10
|
Resverlogix Corp.
|
Mar 18, 2022 09:50PM
|
